IL-12 Genetically Engineered Myeloid Cells in Participants With Relapsed, Refractory Solid Tumors

Clinical trial NCT07672483 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07672483
Sponsor: National Cancer Institute (NCI)
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed Solid Tumor Malignancies Refractory Solid Tumor Malignancies

Start date: 2026-08-23
Primary completion: 2028-01-15
Enrollment: 95

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.